CRH Medical Corp (NYSEMKT:CRHM) Lowered to Accumulate at Bloom Burton

Paterniano Del Favero
Luglio 19, 2017

Zacks Investment Research upgraded CRH Medical Corp from a sell rating to a hold rating in a research note on Tuesday, May 2nd.

Other hedge funds and other institutional investors also recently modified their holdings of the company. ARP Americas LLC boosted its position in shares of CRH Medical Corp by 7.4% in the first quarter. Jane Street Group LLC boosted its stake in shares of CRH Medical Corp by 282.9% in the first quarter. TD Asset Management Inc. boosted its position in shares of CRH Medical Corp by 7.9% in the first quarter. KCG Holdings Inc. now owns 19,486 shares of the company's stock worth $160,000 after buying an additional 5,579 shares in the last quarter. Renaissance Technologies LLC boosted its stake in shares of CRH Medical Corp by 58.1% in the first quarter. Renaissance Technologies LLC now owns 301,300 shares of the company's stock worth $2,470,000 after buying an additional 110,700 shares during the period. Finally, Navellier & Associates Inc acquired a new position in CRH Medical Corp during the first quarter valued at $198,000. Morgan Stanley now owns 1,288,285 shares of the company's stock worth $10,564,000 after buying an additional 652,737 shares during the period. 1,417,784 shares of the company's stock were exchanged. The firm has a 50-day moving average price of $5.77 and a 200 day moving average price of $6.56.

ILLEGAL ACTIVITY WARNING: "Scotiabank Lowers CRH Medical Corp (CRHM) to Sector Perform" was first reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this story on another website, it was copied illegally and republished in violation of USA & global copyright law. The original version of this story can be read at https://baseballnewssource.com/markets/crh-medical-corp-tsecrh-cut-to-accumulate-at-bloom-burton/1224569.html.

The current consensus rating on CRH Medical Corp (TSE:CRH) is Hold (Score: 2.29) with a consensus target price of C$8.75 per share, a potential. Cantor Fitzgerald reiterated an overweight rating and set a $10.00 price target (up previously from $8.00) on shares of CRH Medical Corp in a research note on Monday, March 27th. TD Securities reduced their price objective on CRH Medical Corp from C$12.00 to C$10.50 and set a buy rating on the stock in a report on Friday, July 7th. Four investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. The shares were sold at an average price of C$5.67, for a total value of C$170,100.00.

CRH Medical Corporation is a Canada healthcare services and products company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.

Altre relazioni OverNewsmagazine

Discuti questo articolo

SEGUI I NOSTRI GIORNALE